Última actualización :
Estabilidad y compatibilidad de los medicamentos
Bienvenido a Stabilis. Si desea recibir el boletín de noticias de forma trimestral, indique su dirección de correo electrónico Regístrate

Para cualquier duda o sugerencia, se ruega contactar : infostab@stabilis.org
Bases de datos  
Bibliografía : 2715
Molécula : 840
Clase farmacológica : 46
Estabilidad de las soluciones : 6130
Estabilidad en mezcla : 1213
Compatibilidades : 12078
Nombre comercial : 4607
Novedades - Molécula  
Fármacos contra el cáncer Solución Oral Ruxolitinib 28/06/2022
Varios Inyectables Atosiban 02/06/2022
Varios Solución Oral Epigallocatechin gallate 02/06/2022
Hipoglucemiante Solución Oral Sitagliptine phosphate 02/06/2022
Varios Cápsula Fludrocortisone acetate 05/05/2022
Anti-demencia Solución Oral Pimavanserin 05/05/2022
Fármacos contra el cáncer Solución Oral Imatinib 03/05/2022
Fármacos contra el cáncer Preparaciones tópicas Erlotinib 03/05/2022
Antifúngico Preparaciones tópicas Voriconazole 03/05/2022
Electrólito Inyectables Magnesium chloride 14/03/2022
Inmunosupresor Inyectables Adalimumab 06/03/2022
Hormona Preparaciones tópicas Gestrinone 04/03/2022
Antiinflamatorio Preparaciones tópicas Nimesulide 04/03/2022
Antiinflamatorio Preparaciones tópicas Piroxicam 04/03/2022
Varios Solución Oral Quetiapine fumarate 24/02/2022
Antiinflamatorio Papelinas Hydrocortisone 24/02/2022
Antihipertensor Papelinas Clonidine hydrochloride 24/02/2022
Antálgico Preparaciones tópicas Morphine hydrochloride 24/02/2022
Antibiótico Solución Oral Co-trimoxazole 07/12/2021
Fármacos contra el cáncer Inyectables Isatuximab 01/12/2021
Novedades - Bibliografía  
Fecha de entrada
4692 Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. The Scientific World Journal 10/06/2022
4686 Pertuzumab (Perjeta®) - Summary of Product Characteristics. Roche Products Ltd. 24/05/2022
4683 Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days J Pharm Pract and Res 05/05/2022
4681 An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding. Hosp Pharm 03/05/2022
4679 Stability of extemporaneously prepared sitagliptin phosphate solution. PlosOne 12/04/2022
4676 Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days. EAHP Congress Vienna 05/04/2022
4677 Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags. EAHP Congress Vienna 05/04/2022
4675 Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations. Pharmaceuticals 18/03/2022
4673 Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases. Pharmaceutics 16/03/2022
4670 Stability and Formulation of Erlotinib in Skin Creams. Molecules 09/03/2022
4671 Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents 09/03/2022
4669 Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration. Neuromodulation 03/03/2022
4666 Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron. J Anal Sci Tech 28/02/2022
4667 Stability of Hydromorphone Hydrochloride and Morphine under Different Clinical Infusion Conditions. Int J Pharm Pharm Sci 28/02/2022
4665 LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021 Sanofi Aventis 15/02/2022
4661 Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization J Pharm Biomed Anal 05/02/2022
4655 Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration. Am J Health-Syst Pharm 25/01/2022
4653 Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers. EJHP 24/01/2022
4654 Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 24/01/2022
4652 Nivolumab (Opdivo®) - Summary of Product Characteristics Bristol Myers Squibb Pharmaceuticals 22/01/2022
4651 Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 18/01/2022
4650 Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 12/01/2022
4649 Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices. GaBI Journal 29/12/2021
4648 Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method. PlosOne 16/12/2021
4646 Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates). Int J Pharm Compound 24/11/2021
4645 Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy. JAC Antimicrob Resist 17/11/2021
4643 Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes. EJHP 15/11/2021
4640 Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation. Hosp Pharm 08/11/2021
4641 Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies. Eur J Pharm Sci 08/11/2021
4642 Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 08/11/2021

  Mentions Légales